Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sana Biotechnology Inc (SANA) vs Union Pacific Corporation (UNP) Price & Performance

Sana Biotechnology IncTrade
Union Pacific CorporationTrade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs Union Pacific Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Union Pacific Corporation trades at $295.68 (market cap $175.89B). The key difference: Union Pacific Corporation is far larger — about 201.3× Sana Biotechnology Inc's market cap, and Union Pacific Corporation pays a 1.86% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

SANAUNP
Market Cap
$873.84M$175.89B
Sector
HealthIndustrials
52-Week High
$5.92$301.75
52-Week Low
$2.68$214.91
Enterprise Value
$848.03M$206.36B
Dividend Yield
1.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA

About Union Pacific Corporation

Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.

Read more on UNP